These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32513360)

  • 1. Association of Gleason score with PSA Values and Serum Testosterone Levels Measured Prior To Prostate Biopsy.
    Temel MC; Ediz C; Akan S; Ozer E; Yilmaz O
    J Coll Physicians Surg Pak; 2020 Apr; 30(4):399-402. PubMed ID: 32513360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
    Dell'Atti L
    J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does baseline total testosterone improve the yielding of prostate cancer screening?
    Botelho F; Pina F; Figueiredo L; Cruz F; Lunet N
    Eur J Cancer; 2012 Jul; 48(11):1657-63. PubMed ID: 22342552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
    Porcaro AB; Caruso B; Terrin A; De Luyk N; Cacciamani G; Corsi P; Inverardi D; De Marchi D; Baldassarre R; Cerruto M; Ghimenton C; Brunelli M; Zecchini Antoniolli S; Petrozziello A; Artibani W
    Arch Ital Urol Androl; 2016 Mar; 88(1):17-22. PubMed ID: 27072171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population.
    Na R; Wu Y; Xu J; Jiang H; Ding Q
    PLoS One; 2013; 8(6):e67585. PubMed ID: 23825670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and trends of prostate biopsy for prostate cancer in Chinese men from 2003 to 2011.
    Na R; Jiang H; Kim ST; Wu Y; Tong S; Zhang L; Xu J; Sun Y; Ding Q
    PLoS One; 2012; 7(11):e49914. PubMed ID: 23189170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of pretreatment serum total testosterone measurements with pathology-detected Gleason score cancer.
    Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Romano M; Cavalleri S; Artibani W
    Urol Int; 2014; 93(3):269-78. PubMed ID: 24334919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Huber A; Lümmen G; Tscholl R
    Urology; 2000 Apr; 55(4):481-5. PubMed ID: 10736487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum testosterone improves the accuracy of Prostate Health Index for the detection of prostate cancer.
    Friedersdorff F; Manus P; Miller K; Lein M; Jung K; Stephan C
    Clin Biochem; 2014 Jul; 47(10-11):916-20. PubMed ID: 24530341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
    Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
    BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total thiol can contribute to differentiating prostate cancer from BPH: Prostate Thiol Index as a new player.
    Arpa M; Sen B; Eren H; Uzun H; Okcu O; Erel O
    Andrologia; 2021 Nov; 53(10):e14190. PubMed ID: 34270802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor marker α-fetoprotein receptor does not discriminate between benign prostatic disease and prostate cancer.
    Smrkolj T; Gubina B; Bizjak J; Kumer K; Fabjan T; Osredkar J
    Adv Clin Exp Med; 2017 Oct; 26(7):1085-1090. PubMed ID: 29211355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate Health Index outperforms other PSA derivatives in predicting a positive biopsy in men with tPSA <10 ng/mL: Largest prospective cohort in Taiwan.
    Fan YH; Pan PH; Lin TP; Huang TH; Wei TC; Huang IS; Lin CC; Huang EYH; Chung HJ; Huang WJS
    J Chin Med Assoc; 2019 Oct; 82(10):772-777. PubMed ID: 31356566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opium consumption is negatively associated with serum prostate-specific antigen (PSA), free PSA, and percentage of free PSA levels.
    Safarinejad MR; Asgari SA; Farshi A; Iravani S; Khoshdel A; Shekarchi B
    J Addict Med; 2013; 7(1):58-65. PubMed ID: 23296201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter evaluation of [-2]proprostate-specific antigen and the prostate health index for detecting prostate cancer.
    Stephan C; Vincendeau S; Houlgatte A; Cammann H; Jung K; Semjonow A
    Clin Chem; 2013 Jan; 59(1):306-14. PubMed ID: 23213080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical value of serum isoform [-2] proprostate-specific antigen and its derivatives in predicting aggressive prostate cancer].
    Sun KX; Yan CL; Li ZY; Liu P; Zhang W; He Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Apr; 52(2):234-239. PubMed ID: 32306004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.
    Haese A; Graefen M; Steuber T; Becker C; Noldus J; Erbersdobler A; Huland E; Huland H; Lilja H
    J Urol; 2003 Dec; 170(6 Pt 1):2269-73. PubMed ID: 14634394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
    Chun FK; Perrotte P; Briganti A; Benayoun S; Lebeau T; Ramirez A; Lewinshtein DJ; Valiquette L; Guay JP; Karakiewicz PI
    BJU Int; 2006 Jul; 98(1):50-3. PubMed ID: 16831142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.